Letters Anticoagulation in AF

Anticoagulation uptake remains poor in high risk patients

BMJ 2011; 342 doi: http://dx.doi.org/10.1136/bmj.d1153 (Published 22 February 2011) Cite this as: BMJ 2011;342:d1153
  1. Campbell Cowan, national clinical lead for arrhythmias, NHS Improvement—Heart1,
  2. Matthew Fay, national clinical lead for stroke prevention, NHS Improvement—Stroke2,
  3. Kathryn Griffith, president, Primary Care Cardiovascular Society3,
  4. Damian Jenkinson, national clinical lead for stroke, NHS Improvement—Stroke4
  1. 1General Infirmary at Leeds, Leeds LS1 3EX, UK
  2. 2Westcliffe Medical Centre, Shipley, West Yorkshire BD18 3EE, UK
  3. 3Dr Price and Partners, York YO10 4DU, UK
  4. 4Royal Bournemouth Hospital, Bournemouth BH7 7DW, UK
  1. campbell.cowan{at}leedsth.nhs.uk

Olesen and colleagues validate the predictive value of the CHA2DS2VASc score among patients admitted to hospital with atrial fibrillation (AF), showing its superiority to the traditional CHADS2 score in identifying patients at low risk of stroke.1 However, even among patients with identified atrial fibrillation and identifiable risk factors, the uptake of anticoagulation …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial